Additional file 4: Table S4. Univariate Cox regression analysis of overall survival and ridge regression coefficients of drug resistance signature alone in the training dataset.
IRAK4 in complex with AZ3864 Descriptor: (3~{a}~{R},7~{a}~{S})-1-methyl-5-[4-[[5-(oxan-4-yl)-7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclohexyl]-3,3~{a},4,6,7,7~{a}-hexahydropyrrolo[3,2-c]pyridin-2-o
To explore potential miRNAs dysregulated in DLBCL, we evaluated the miRNA profiles using tissue samples from 10 patients diagnosed with DLBCL. Reactive lymph nodes served as controls. miRNA microarray
Diffuse large B-cell lymphoma (DLBCL), the most common form of non-Hodgkin lymphoma, is characterized by an aggressive clinical course. In approximately one-third of DLBCL patients, first-line multi-a
